跳转至内容
Merck
CN
  • Isotope labeling pattern study of central carbon metabolites using GC/MS.

Isotope labeling pattern study of central carbon metabolites using GC/MS.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2014-12-03)
Joon-Young Jung, Min-Kyu Oh
摘要

Determination of fluxes by (13)C tracer experiments depends on monitoring the (13)C labeling pattern of metabolites during isotope experiments. In metabolome-based (13)C metabolic flux analysis, liquid chromatography combined with mass spectrometry or tandem mass spectrometry (LC/MS or LC/MS/MS, respectively) has been mainly used as an analytical platform for isotope pattern studies of central carbon metabolites. However, gas chromatography with mass spectrometry (GC/MS) has several advantages over LC/MS, such as high sensitivity, low cost, ease of operation, and availability of mass spectra databases for comparison. In this study, analysis of isotope pattern for central carbon metabolites using GC/MS was demonstrated. First, a proper set of mass ions for central carbon metabolites was selected based on carbon backbone information and structural isomers of mass fragment ions. A total of 34 mass fragment ions was selected and used for the quantification of 25 central carbon metabolites. Then, to quantify isotope fractions, a natural mass isotopomer library for selected mass fragment ions was constructed and subtracted from isotopomer mass spectra data. The results revealed a surprisingly high abundance of partially labeled (13)C intermediates, such as 56.4% of fructose 6-phosphate and 47.6% of dihydroxyacetone phosphate at isotopic steady state, which were generated in the pentose phosphate pathway. Finally, dynamic changes of isotope fragments of central metabolites were monitored with a U-(13)C glucose stimulus response experiment in Kluyveromyces marxianus. With a comprehensive study of isotope patterns of central carbon metabolites using GC/MS, 25 central carbon metabolites and their isotopic fractions were successfully quantified. Dynamic and precise acquisition of isotope pattern can then be used in combination with proper kinetic models to calculate metabolic fluxes.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
吡啶, ACS reagent, ≥99.0%
Sigma-Aldrich
吡啶, suitable for HPLC, ≥99.9%
Sigma-Aldrich
吡啶, anhydrous, 99.8%
Sigma-Aldrich
吡啶, ReagentPlus®, ≥99%
Sigma-Aldrich
乙酸酐, ReagentPlus®, ≥99%
Sigma-Aldrich
乙酸酐, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99% (GC)
Sigma-Aldrich
乙酸酐, ACS reagent, ≥98.0%
Sigma-Aldrich
吡啶, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99.5% (GC)
Sigma-Aldrich
磷酸-丙酮酸 三钠盐 水合物, ≥97% (enzymatic)
Sigma-Aldrich
1,2,3,4-丁四醇, ≥99% (GC)
Sigma-Aldrich
吡啶, ≥99%
Supelco
N -甲基-双(三氟乙酰胺), derivatization grade (GC derivatization), LiChropur, ≥97.0% (GC)
Sigma-Aldrich
吡啶, biotech. grade, ≥99.9%
Sigma-Aldrich
二羟丙酮磷酸盐 二锂盐, ≥93% dry basis (enzymatic)
Supelco
乙酸酐, derivatization grade (GC derivatization), LiChropur, ≥99.0%
Sigma-Aldrich
吡啶, ACS reagent, ≥99.0%
Supelco
吡啶, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
吡啶, analytical standard
Supelco
N -甲基-双(三氟乙酰胺), derivatization grade (GC derivatization), LiChropur, ≥99.0% (GC)
Sigma-Aldrich
L -焦谷氨酸 2-萘酰胺, ≥99% (TLC)
Sigma-Aldrich
吡啶, ReagentPlus®, ≥99%
1,2,3,4-丁四醇, European Pharmacopoeia (EP) Reference Standard